Mikuls Ted R, Saag Kenneth G, George Varghese, Mudano Amy S, Banerjee Samprit
Department of Medicine, Section of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska 68198-3025, USA.
J Rheumatol. 2005 May;32(5):870-5.
To examine potential racial/ethnic disparities in osteoporosis care among community-dwelling older women with self-reported arthritis and previous fracture.
We conducted a computer assisted telephone interview using a population based random sample drawn from 6 counties in Alabama, USA. Eligible respondents had self-reported arthritis and were over 50 years of age; 1424 people responded to the survey. Logistic regression was used to examine the association of race/ethnicity with the receipt of dual energy x-ray absorptiometry (DEXA) and prescription osteoporosis treatments (including bisphosphonates, calcitonin, hormone replacement, or selective estrogen receptor modulators) among older women with a history of fracture.
Of eligible African American and Caucasian female respondents, 251 (25%) reported a history of fracture after 45 years of age. Women with a history of self-reported fracture were predominantly Caucasian (n = 178, 71%) and had a mean age of 68 +/- 11 years. After multivariable adjustment, African American women with a fracture history were less likely than Caucasian women with a history of fracture to receive a DEXA (OR 0.39, 95% CI 0.19-0.81) or prescription osteoporosis medicines (OR 0.17, 95% CI 0.08-0.37).
In this population of community-dwelling older women, African American respondents at high risk for fracture were far less likely than Caucasians to receive osteoporosis related healthcare.
研究社区居住的患有自我报告的关节炎和既往骨折史的老年女性在骨质疏松症护理方面潜在的种族/民族差异。
我们使用从美国阿拉巴马州6个县抽取的基于人群的随机样本进行了计算机辅助电话访谈。符合条件的受访者自我报告患有关节炎且年龄超过50岁;1424人回应了调查。逻辑回归用于研究种族/民族与有骨折史的老年女性接受双能X线吸收法(DEXA)和骨质疏松症处方治疗(包括双膦酸盐、降钙素、激素替代或选择性雌激素受体调节剂)之间的关联。
在符合条件的非裔美国女性和白人女性受访者中,251人(25%)报告有45岁以后的骨折史。有自我报告骨折史的女性主要是白人(n = 178,71%),平均年龄为68±11岁。经过多变量调整后,有骨折史的非裔美国女性比有骨折史的白人女性接受DEXA检查(比值比0.39,95%置信区间0.19 - 0.81)或骨质疏松症处方药物治疗(比值比0.17,95%置信区间0.08 - 0.37)的可能性更小。
在这群社区居住的老年女性中,有骨折高风险的非裔美国受访者比白人接受骨质疏松症相关医疗保健的可能性要小得多。